FAQs How do I know if GLP-1 treatment may be working
GIP supplementation was also shown to be ineffective in the 1990s when intravenous (IV) GIP was introduced to hyperglycemic patients with no effect on their blood glucose though physiologic rather than pharmacologic concentrations were supplied [20]
They help activate GLP-1 receptors in the body, which causes the release of the GLP-1 hormone
The pharmacokinetics of these injectable medications are designed for subcutaneous administration, and absorption rates may vary slightly depending on the injection site chosen, though clinical significance of these variations is generally minimal
Tirzepatide is a GLP-1 receptor agonist too, but it is also a GIP (glucose-dependent insulinotropic polypeptide) receptor agonist
GLP-3 medications like retatrutide may be appropriate for individuals who: Have experienced plateaus with GLP-1 medications Struggle with metabolic resistance Want a more comprehensive, physician-guided solution For additional insight into how hormone-based therapies are used at Inner Glow, explore our advanced weight loss treatments